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Aim: To confirm the biological effects of manganese ferrite magnetic nanoparticles (MFMNPs) and an
external magnetic field on glioblastoma cells. Methods: U-87MG glioblastoma cells were prepared, into
which the uptake of MFMNPs was high. The cells were then exposed to an external magnetic field using
a neodymium magnet in vitro and in vivo. Results: LRP6 and TCF7 mRNA levels involved in the Wnt/β-
catenin signaling pathway were elevated by the influence of MFMNPs and the external magnetic field.
MFMNPs and the external magnetic field also accelerated tumor growth by approximately 7 days and
decreased survival rates in animal experiments. Conclusion: When MFMNPs and an external magnetic field
are applied for a long time on glioblastoma cells, mRNA expression related to Wnt/β-catenin signaling is
increased and tumor growth is promoted.
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Magnetic nanoparticles (MNPs) have mostly been studied as MRI contrast agents, drugs and gene carriers. MNPs
have also been researched and developed in various fields involving the application of their magnetic characteristics,
particularly artificial receptor clusterization for cell growth signaling, cell capture using microfluidic chips, and in
vivo control of stem cell migration and differentiation [1–3]. As the number of studies using MNPs and magnetic
fields has increased, studies on the correlation between MNPs and magnetic fields have been conducted. In MNPs,
raw materials, sizes and surface charges are related to cytotoxicity, and there are many opinions on the genetic
changes they can cause [4,5].
A high-strength static magnetic field (4.7 T) alters the ability of human malignant melanoma cells to remain
adherent to their tissue culture surface but does not have the same effect on normal human fibroblasts [6]. In
addition, a stronger static magnetic field (7 T) delays the growth of three human tumor cell lines [7]. Recent studies
have shown that a magnetic field can cause physical interactions that can change mesenchymal stem cell shape,
function and fate [8]. For example, a static magnetic field produced MNP aggregates that induced an unsuspected
cytotoxicity effect both in vitro and in vivo [9]. In addition, MNPs might induce apoptosis by an extremely low-
frequency magnetic field [10]. Nevertheless, many studies using MNPs and magnetic field have been conducted.
For example, anti-Frizzled functionalized MNPs and magnets activated the Wnt/β-catenin signaling pathway in
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human mesenchymal stem cells [11]. In one study of hyperthermia treatment, an external alternating magnetic field
killed cancer cells by the effect of raising the temperature around the MNPs [12]. Despite the high biological and
medical application potential of MNPs, studies on MNPs and magnetic field interaction have not been conducted
sufficiently. The opinions on its influence also vary [13–16].
Manganese ferrite MNPs (MFMNPs) have been demonstrated not only to have higher magnetization than
other metal-doped iron oxide nanoparticles, such as CoFe2O4 and NiFe2O4, but also to enable ultrasensitive
targeted MRI in vivo. MFMNPs have previously shown great potential as T2 contrast agents because they greatly
improve cancer cell detection sensitivity and enable in vivo MRI of small tumors [17]. In addition, MFMNPs can
be phase-transferred using amphiphilic polymers and functionalized, making it easy to attach antibodies, peptides
or other molecules to them. For these reasons, MFMNPs have been primarily studied as agents for molecular MRI,
multimodal imaging, drug delivery and gene delivery [18–21].
This study utilized MFMNPs and an external magnetic field to assess the changes they elicited in tumor cell
mRNA expression levels and tumor growth. To ensure high uptake of MFMNPs into U-87MG glioblastoma cells,
the well-known transfection agent poly-l-lysine (PLL) was used. Cells containing MFMNPs were then exposed to
an external magnetic field using a neodymium magnet. Following this, the level of Wnt/β-catenin signaling-related




1,2-hexadecanediol, manganese(II) acetylacetonate, iron(III) acetylacetonate, dodecanoic acid, dodecylamine,
benzyl ether and polysorbate 80 were purchased from Sigma-Aldrich (MO, USA). Phosphate-buffered saline
(PBS, 10mM, pH 7.4), Dulbecco’s modified Eagle medium, fetal bovine serum and antibiotic–antimycotic so-
lution were purchased from Thermo Fisher Scientific (Gibco, MA, USA). U-87MG cells were purchased from
the American Type Culture Collection (VA, USA). The CCK-8 assay kit was purchased from Dojindo Molecular
Technologies, Inc. (MD, USA). Ultrapure deionized water was used for all syntheses. All other chemicals and
reagents were analytical grade.
Synthesis of MFMNPs
The thermal decomposition method was used to synthesize monodispersed MFMNPs [22]. The method was per-
formed according to previously reported procedures [17]. Iron(III) acetylacetonate (2 mmol), manganese(II) acety-
lacetonate (1 mmol), 1,2-hexadecanediol (10 mmol), dodecanoic acid (6 mmol) and dodecylamine (6 mmol) were
dissolved in 20 ml benzyl ether under nitrogen gas atmosphere [23]. The mixture was then preheated at 200◦C for
2 h and refluxed at 300◦C for 30 min. After reflux, the reactants were cooled at room temperature sufficiently and
then purified with an excess of 99.9% ethanol. MFMNPs were synthesized up to approximately 12 nm in diameter
using the seed-mediated growth method. MFMNP seeds (100 mg) were dispersed in 4 ml hexane, then the mixture
was heated to a maximum of 100◦C at 10◦C/min, stirred for 30 min to remove hexane, then heated again at
200◦C. These processes were performed twice to get 12-nm MFMNPs.
Preparation of MFMNPs
MFMNPs were prepared by the nanoemulsion method [19]. MFMNPs were dissolved in hexane (7.5 mg/ml, organic
phase). The amphiphilic polymer polysorbate 80 was dissolved in deionized water (5 mg/ml, aqueous phase). The
two solutions were mixed and sonicated using a Teflon impeller in a 4◦C bath for 15 min. The remaining hexane
was evaporated overnight at room temperature, and the products were concentrated and purified using a centrifugal
filter (Centriprep YM-3, Merck, Darmstadt, Germany). The hydrodynamic size distribution of MFMNPs was
analyzed by dynamic laser scattering (ELS-Z, Otsuka Electronics Co., Osaka, Japan). The morphology of MFMNPs
was confirmed using transmission electron microscopy (JEM-2100, JEOL, Tokyo, Japan). The Mn and Fe ion
concentrations from nanoparticles were calculated by inductively coupled plasma–optical emission spectrometer.
Cytotoxicity
To evaluate the cytotoxicity of MFMNPs, the CCK-8 cell proliferation/cytotoxicity assay kit was used. U-87MG
cells were seeded into a 96-well culture plate (2 × 104 cells/well) and cultured for 24 h at 37◦C in a humidified
atmosphere with 5% CO2. Cells were treated with MFMNPs and MFMNPs with PLL at various concentrations
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for 24 h. For the MFMNPs with PLL, 25 μg/ml MFMNPs were incubated with PLL (1.5 μg/ml) for 5 min,
serially diluted twofold to make nine aliquots and administered to U-87MG cells for 24 h. After treatment, cells
were treated with the CCK-8 solution according to the manufacturer’s instructions. Cell viability was evaluated
spectrophotometrically using a microplate reader (Synergy H1, BioTeck Instruments, VT, USA) at 450 nm.
All experiments were performed in triplicate. The PLL concentration was determined according to the method
reported by Yun et al. [1].
Prussian blue staining
Prussian blue staining was used to evaluate the efficacy of the delivery of MFMNPs using PLL. Based on the results
of cytotoxicity experiments, the concentrations of MFMNPs (25 μg/ml) and PLL (1.5 μg/ml) were determined.
First, U-87MG cells (2 × 106) were incubated with MFMNPs for 4 h at 37◦C. Second, the cells were washed with
warm PBS and then fixed with 4% paraformaldehyde. Third, to dye the MNPs, 10% potassium ferrocyanide and
20% hydrochloric acid were mixed in a 1:1 ratio. The fixed U-87MG cells were treated with the mixed dye solution
for 30 min at room temperature. After staining, the cells were washed with deionized water, and the nucleus was
counterstained for 30 min using a nuclear fast red solution (Sigma-Aldrich, MO, USA). Finally, the cells were
observed using an optical microscope (CKX41, Olympus, Tokyo, Japan).
Migration assay
To evaluate the migration effects under an external magnetic field, 25 μg/ml MFMNPs were incubated with
1.5 μg/ml PLL for 5 min and added to a trypsinized single-cell suspension of U-87MG cells (2 × 106). After
4 h, cells were washed with PBS thrice, seeded in six-well plates (2.5 × 105 cells/well) and cultured at 37◦C in a
humidified atmosphere with 5% CO2. After 1 day, the half-side of the wells was wiped out with a cell scraper, and
the neodymium magnets were attached on the right side of the wells. Cells were observed daily using an optical
microscope.
Quantitative real-time PCR
Whole RNA was purified using MasterPure™ RNA purification kit (Epicentre Biotechnologies, WI, USA) ac-
cording to the manufacturer’s protocol. The RNA concentration was determined using the Nanodrop 2000
spectrophotometer (Thermo Fisher Scientific, MA, USA). cDNA was synthesized from 1000 ng total RNA using a
High-Capacity RNA-to-cDNA kit (Applied Biosystems, CA, USA). qRT-PCR was performed using a SensiFAST™
SYBR R© Lo-ROX kit (Bioline, Luckenwalde, Germany), and PCR was executed using a ViiA 7 Real-time PCR
System (Thermo Fisher Scientific, MA, USA). PCR was performed in triplicate, and samples were normalized to
GAPDH and β-actin expression levels. The PCR was performed 40 cycles as follows: 3 min initial denaturation at
95◦C, denaturation at 95◦C for 10 s each, annealing at 60◦C for 30 s each, extension at 72◦C for 30 s and then
72◦C for 5 min for a final extension.
Mouse tumor modeling
Male athymic BALB/c nude mice aged 5 weeks (Orient Bio, Seongnam, Korea) were used for tumor xenograft
experiments. Mice were retained in microisolator cages under sterile conditions and observed for at least 1 week
before the study initiation to ensure proper health. Temperature, lighting and humidity were controlled centrally.
All experimental procedures were approved by the Yonsei University College of Medicine Institutional Animal Care
and Use Committee and were carried out in accordance with the committee’s guidelines. Before the experiments,
all mice were anesthetized with 2% isoflurane. In the heterotopic xenograft mouse model, 2 × 106 U-87MG cells
were implanted into the right thigh using a 29-gauge needle. The orthotopic brain tumor xenograft model was
drilled on the mouse skull using a 26-gauge needle. U-87MG cells (1 × 105) were implanted directly into the
right frontal lobe of nude mice using a Gastight syringe (Hamilton Co., NV, USA) at a depth of 4.5 mm. Cells
were simultaneously injected into each mouse using a multiple microinfusion syringe pump (Harvard Apparatus,
MA, USA) at a rate of 0.5 μl/min, as described previously [24]. After U-87MG implantation, ring-type 3000-
gauge neodymium magnets were attached to the right thigh, and 2000-gauge disk-type neodymium magnets were
attached to the forehead using a medical adhesive (3M Vetbond Tissue Adhesive, 3M Co., MN, USA). While
transplanting U-87MG glioblastoma cells, tumor growth could generally be visually confirmed from about 3 weeks.
Because the MFMNPs were able to maintain their magnetic properties for 2 or more weeks even after entering the
mouse’s body, neodymium magnets were attached for 2 weeks (Supplementary Figure 1). Each mouse was housed
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in a separate cage to avoid the influence of magnets attached to other mice. The tumor volume and survivals were
recorded at least twice a week (tumor volume was measured after the removal of the magnets).
Magnetic resonance imaging
T2-weighted MRI experiments were investigated with a 9.4 T Bruker 20-cm bore animal MRI system (Biospec
94/20 USR, Bruker Medical Systems, Karlsruhe, Germany) equipped with a 40-mm inner diameter quadrature
radiofrequency coil (RF SUC 400 1H M-BR-LIN Road, Bruker Medical Systems, Karlsruhe, Germany). For animal
MRI, anesthesia was induced by 3% and maintained with 2% isoflurane in a mixture of 70% N2O and 30% O2.
The respiration rate was monitored with a small animal respiration pad (Model 1025 Small Animal Monitoring
and Gating System; SA Instruments, Inc., NY, USA), and the body temperature was supported by a warm-water
tube integrated into the animal bed. Magnetic resonance images were acquired with the following sequence: coronal
T2-weighted rapid acquisition with relaxation enhancement (repetition time = 1800 ms, echo time = 22.2 ms,
slice thickness = 0.50 mm, acquisition matrix = 274 × 200, field of view = 2.50 × 1.80 cm, flip angle = 180.0◦).
The relaxivity values of R2 were calculated by a series of T2 values when plotted as 1/T2 versus Fe and Mn. The
relaxivity coefficient (mM-1 s-1) was equal to the ratio of R2 (1/T2; s-1) to the MFMNP concentration.
Results
Characterization of MFMNPs
The morphology and size of MFMNPs were confirmed using transmission electron microscopy. In the electron
microscope image, there was no abnormality in the appearance of MFMNPs and the size was constant and
monodisperse. After nanoemulsion, the hydrodynamic size of MFMNPs was 36.2 ± 10.3 nm as determined by
dynamic light scattering (Figure 1A). The potential magnetism to serve as an MRI contrast agent was confirmed
using a 9.4-T animal MRI system. As the concentration of MFMNPs increased, the T2 relaxivities (R2) of
MFMNPs linearly increased and the T2 relaxivity coefficient was 462.2 mM-1 s-1 (Figure 1B). The relaxivity
reflected how the relaxation rates of MNPs changed as a function of concentration. The R2 value was defined
as the ratio of Fe concentration that MFMNPs contained to the inverse of the T2 relaxation time, measured by
the magnetic resonance signal intensity from the difference of T2 relaxation times. These results suggested that
MFMNPs were stably dispersed in the aqueous phase, with the potential to be used as a T2 MR contrast agent, and
that susceptibility could be sufficiently obtained by an external magnetic field in an experiment to be conducted in
the next step.
Cytotoxicity & cellular affinity of MFMNPs with PLL
PLL is a cationic polymer used for gene transfection and MNP transfer to cells [2]. To determine the cytotoxicity
of MFMNPs and PLL, the viability of U-87MG cells exposed to various concentrations of each condition was
evaluated (Figure 2A). Cytotoxicity was assessed using the CCK-8 assay in ten concentrations. The highest
concentrations were 25 μg/ml MFMNPs and 15 μg/ml PLL diluted twofold to make nine aliquots. There was
no significant cytotoxicity until 25 μg/ml treated MFMNPs. In treated MFMNPs with PLL, only the 25 μg/ml
condition showed about 85% cell viability. All subsequent experiments were conducted at MFMNP concentrations
resulting in >85% cell viability. To evaluate higher cellular uptake efficiency using PLL, Prussian blue staining was
carried out. Magnetic ions in cells treated with MFMNPs and MFMNPs with PLL were combined with injected
ferrocyanide, resulting in the appearance of a bright blue color. In U-87MG cells treated with PLL and MFMNP,
several blue spots could be observed by Prussian blue staining (Figure 2B). These results indicated that the cellular
delivery of MFMNPs using PLL is safe and effective.
Migration effects of an external magnetic field
Cell migration experiments with an external magnetic field were performed for three reasons: to confirm the change
in cell migration, to confirm the change in mRNA expression level produced by an external magnetic field and to
check the magnetic field was of sufficient distance for the next animal experiment. To evaluate the migration effects
of an external magnetic field, U-87MG cells were cultured in six-well culture plates under various conditions.
Neodymium magnets were attached to the right side of the wells, and cells were observed daily using a microscope.
On day 2, cells with MFMNPs and PLL under magnetic field were growing toward the magnets more than in the
other conditions. On day 3, the difference in cell distribution was clearly confirmed. There were no significant
differences in U-87MG cells using magnets, MFMNPs or PLL alone (Figure 3). In addition, the movement of
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Figure 1. Characterization of manganese ferrite magnetic nanoparticles. (A) Hydrodynamic size and transmission
electron microscopy image of manganese ferrite magnetic nanoparticles. (B) T2 MRI and graph for relaxivity
coefficients around manganese ferrite magnetic nanoparticles.
cancer cells containing MFMNPs toward the magnet showed that the distance between the magnet and the cell
was close enough to affect the cell. Because the diameter of one well of a six-well plate was 3.5 cm, the distance
from the outermost surface of the cells to the magnet was predicted to be about 1.75 cm. Therefore the distance
between cells and magnets was kept within 1.75 cm in the next in vivo experiment.
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Figure 2. Cell viability and effects of poly-L-lysine. (A) CCK-8 assay of U-87MG glioblastomas cells using MFMNPs and MFMNPs with PLL.
(B) Prussian blue staining of U-87MG glioblastoma cells. The ionic iron of MFMNPs reacts with acid ferrocyanide, producing a blue color.
MFMNP: Manganese ferrite magnetic nanoparticle; PLL: Poly-L-lysine.
Confirmation of mRNA expression change by an external magnetic field
After the cell migration experiment, cells were trypsinized and RNA was purified. Then the expression levels of
seven mRNAs – Axin2, LRP6, TCF7, MYCN, SP5, ID2 and EPHB3, known to be increased due to chronic
metabolic stress in cancer stem cell-like cells – were measured [25]. Under external magnetic field conditions, LRP6
and TCF7 mRNA levels were elevated, but changes in the levels of the other five mRNAs could not be confirmed as
significant (Figure 4). In the qRT-PCR analysis, both mRNAs increased only when affected by MFMNPs, PLL and
the external magnetic field, but did not increase significantly when only one or two of these three conditions were
affected. The mRNA level was slightly increased in the magnet-only group, but this phenomenon was also observed
for all other mRNAs. mRNA expression was normalized to the endogenous reference genes (β-actin and GAPDH)
in the corresponding samples relative to untreated cells. These results demonstrated that MFMNP and an external
magnetic field affect mRNA expression.
Effects of the external magnetic field on tumor growth & metastasis
To confirm the effects of MFMNPs and the external magnetic field in the in vivo model, U-87MG glioblastoma
cells (treated with MFMNPs and untreated) were implanted in the right thigh of each of the three mice, and
magnets were placed on the thighs for 2 weeks. All mice were isolated in separate cages to avoid the influence of
other magnets. After removing the magnet, the tumor volume was recorded at least twice a week. Interestingly,
when the tumors of each of the three mice grew measurably, the external magnetic field accelerated the tumor
growth rate by 7 days (Figure 5A & B). It took 24 days for the tumor sizes of the three mice unaffected by the
external magnet to be measurable, but only 17 days to measure the tumor size in mice affected by the external
magnet. In addition, when U-87MG cells without MFMNPs were implanted and only magnets were attached, it
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Figure 3. Cell migration assay with external magnetic field under various conditions. The magnets were located on
the right side of each well.
































Figure 4. qRT-PCR graph of LRP6 and TCF7 mRNA under various conditions. U-87MG glioblastoma cells were
exposed to an external magnetic field for 72 h.
MFMNP: Manganese ferrite magnetic nanoparticle; PLL: Poly-L-lysine.
took 22 days to measure the tumors in the three mice (Figure 5C). The tumor grew slightly faster; this result was
predicted to be associated with the slight increase in the mRNA levels of LRP6 and TCF7 when cells were treated
with magnets only in the in vitro qRT-PCR experiments (Figure 4). After 33 days, the animal experiment was
ended according to the humane end point criteria, and the tumors were confirmed by MRI.
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Figure 5. Increased tumor growth by manganese ferrite magnetic nanoparticles and external magnetic field. Graph of mouse tumor
volume and the first day when tumor size could be measured in all three mice. The photos and magnetic resonance images were taken
on day 33.
Magnet: External magnetic field; MFMNP: Manganese ferrite magnetic nanoparticle.
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Figure 6. Effects of manganese ferrite magnetic nanoparticles and external magnetic field on tumor metastasis and
mRNA expression. (A) Photographs of organs of each mouse. (B) LRP6 and TCF7 qRT-PCR graph of the tumors, lungs
and liver.
Magnet: External magnetic field; MFMNP: Manganese ferrite magnetic nanoparticle.
After the tumor growth experiment, metastasis was confirmed for each mouse. In mice transplanted with U-
87MG glioblastoma cells treated with only MFMNPs and those with U-87MG glioblastoma cells treated with
MFMNPs and attached magnets, two of three mice in each group showed metastasis to the lungs and liver
(Figure 6A). Interestingly, in the mouse group with only the magnet attached, metastasis could not be identified in
the lungs or liver (Supplementary Figure 2).
LRP6 and TCF7 mRNA expression levels were identified in primary tumors, lungs and liver. The number of
metastatic tumor nodules was similar, but the level of mRNA expression was different. As shown in Figure 6B,
the LRP6 mRNA level showed no particular difference between the groups, but TCF7 mRNA expression was higher
in the liver and lung tissues of mice affected by external magnets than in mice not affected by external magnets.
These results provide evidence that changes in TCF7 expression occur when both MFMNPs and external
magnetic fields affect glioblastoma. Given that metastatic cancer can occur under various conditions, the influence
of MFMNPs and external magnets does not unconditionally cause metastasis. The difference in the amount of
TCF7 expression may have occurred depending on the degree of metastatic cancer development (size and severity
of the neoplasm).
Change of survival rate in the orthotopic xenograft model
U-87MG cells were implanted with MFMNPs in the right frontal lobe of ten mice, and the effect of the external
magnetic field on survival was confirmed. Because space inside the skull is limited, it was predicted that if the
rate of tumor growth were different between the groups, there would be differences in mouse survival. Tumor size
was checked using MRI once a week. After 14 days, the tumor under the external magnet was bigger than in the
other conditions (Figure 7A). After 23 days, only one mouse affected by an external magnet had survived, but five
unaffected mice survived (Figure 7B). In the orthotopic xenograft model, the distance between the tumor cells and
the magnet was slightly longer than in the heterotopic xenograft model; however, it was a sufficient distance to
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Figure 7. MRIs and survival graph of the orthotopic xenograft model. (A) T2 MRI of a mouse brain on day 14.
Tumors are indicated by yellow dashed lines. (B) Kaplan–Meier survival graph of mice with and without an external
magnetic field.
Magnet: External magnetic field; MFMNP: Manganese ferrite magnetic nanoparticle.
promote the growth of tumor cells. These results demonstrated that MFMNPs and the external magnetic field had
an effect in both heterotopic and orthotopic xenograft models. Because the brain has limited internal space, the
difference in the rate of tumor growth is more pronounced.
Discussion
Experimental data on the risks of nanoparticles published in the field of nanotoxicology have grown steadily in the
past 20 years. The potential for problems arises from the inherent physicochemical properties (material, size, surface
charge, etc.) of nanoparticles and their interaction with living organisms and complex biological environments.
The magnetic field is known to have biological influences in some specific situations, such as high-strength static
magnetic field [26]. However, most of these effects do not have fatal consequences [27]. Many MNPs have been
used to target tumor cells using a magnetic field to improve efficacy in molecular imaging, drug delivery, gene
delivery, cell isolation and therapeutic applications. However, little is known about what happens after cancer cells
are constantly exposed to MNPs and an external magnetic field.
Therefore this study focused on the effects of MNPs and an external magnetic field on tumor cells. Placing a
neodymium magnet near a glioblastoma cell treated with MNPs showed that cells grew toward the magnet over
time and were affected by the external magnetic field. It was confirmed that the expression of two Wnt/β-catenin
signaling-related mRNAs was increased in glioblastoma cells affected by MNPs and the external magnetic field.
Expression of these two mRNAs did not change significantly when only MNPs were used or when only the external
magnetic field was used, but they increased significantly when both conditions were applied together.
LRP6 is a coreceptor with LRP5 and Frizzled protein family members which transmit signals by Wnt proteins
through the canonical Wnt/β-catenin signaling pathway. Wnt binding to Fzd/LRP6 activates what has traditionally
been considered a linear signaling cascade, leading to the stabilization of β-catenin. Increased LRP6 expression is
known to trigger Wnt activation, cell proliferation and, typically, tumorigenesis [28–30]. In colorectal cancer, LRP6
promotes invasion and metastasis through cytoskeleton dynamics [31]. Hence LRP6 is recognized and studied as a
promising anticancer target.
The TCF7 protein binds to β-catenin and plays an essential role in Wnt signaling. After binding to β-catenin,
the β-catenin/TCF7 complex activates the transcription of the Wnt target gene and, as a result, promotes cell
growth and cell migration [32]. TCF7 was overexpressed in several malignant tumors, such as colorectal and breast
tumors [33–35] and its expression is correlated with cellular proliferation, invasion or metastasis in gastric and lung
cancers.
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Because both mRNAs (LRP6 and TCF7) are known to promote tumor growth, the tumor growth rate was
confirmed by implanting glioblastoma cells containing MNPs into BALB/c nude mice. MFMNPs were introduced
into glioblastoma cells using a cationic polymer, PLL, and then implanted into mice. If a magnetic field is used to
introduce MFMNPs into glioblastoma cells, it is expected that the amount of nanoparticles introduced into cells
will increase [36]. However, in Prussian blue-stained images, a sufficient number of particles were introduced into
cells using only PLL. In addition, because this study refers to changes in mRNA expression when MFMNPs are
introduced into cells and under the influence of an external magnetic field, the intervention of the external magnetic
field should be minimized in the process of introducing MFMNPs. Also, because MFMNPs were introduced into
glioblastoma cells and then transplanted into mice, it is unlikely that MFMNPs will have a toxic effect on normal
cells or normal tissues. Because all MFMNPs were used at a cell viability concentration of 80% or more using the
CCK-8 assay kit, the experimental results should be viewed as demonstrating the influence of MFMNPs and the
external magnetic field rather than the toxicity of MFMNPs. In all animal experiments, there were no acute deaths
or abnormal behaviors caused by the MFMNPs or external magnetic fields. After the end of the animal experiment,
the organs of each mouse were checked, and there was no bleeding, swelling or inflammation other than metastatic
cancer.
In a model with a heterotopic xenograft on the thigh of a mouse, glioblastoma cells affected by both the MFMNPs
and external magnetic field grew 1 week faster than the control group. Liver and lung metastases were identified
in each group. Interestingly, TCF7 expression was very high in the liver tissues of mice, influenced by both the
MFMNPs and external magnetic field, while the level of both mRNAs was low in the primary tumor. This is
probably because the mRNA expression level changes as the tumor grows [37,38]. In a tumor metastasized to the
lung or liver, it is expected that TCF7 expression could be confirmed because it began to grow later than the primary
cancer. TCF7 is an important factor in metastasis, and overexpressed TCF7 has been shown to be correlated with
metastasis and low survival rate [39,40]. It is believed that these characteristics of TCF7 also appeared in the mouse
model in the study. Even when glioblastoma cells were transplanted into the mouse brain, the tumor growth of
mice affected by MFMNPs and the external magnetic field was faster than in the control group; as a result, survival
was poorer than in the control group.
Three mice died in the early days (4–7 days after tumor cell implantation) in an orthotopic xenograft model
experiment. As shown in Supplementary Figure 1, the magnetic properties of MFMNPs were introduced into
glioblastoma cells and lasted at least 18 days after mouse implantation. Therefore it was predicted that glioblastoma
cells into which MFMNPs were introduced immediately after tumor cell transplantation were sufficiently affected
by an external magnetic field. Unlike the heterotopic xenograft experiments, the orthotopic experiments were
subject to the brain’s space limitations, so even in the early stages of tumor growth, it was understood that mice
could die depending on the location and direction of the tumor growth.
Conclusion
MNPs have a very high utility value as a contrast agent and a carrier. To use these particles more effectively, they
are often used with an external magnetic field. This study dealt with the biological changes induced by MNPs,
especially MFMNPs and the external magnetic field, on glioblastoma. The findings suggest that long-term use of
MNPs and an external magnetic field is highly involved in the Wnt/β-catenin signaling pathway and may increase
the expression of two mRNAs closely related to tumor growth and metastasis. Both orthotopic and heterotopic
xenograft mouse models showed a tendency to accelerate tumor growth. In the heterotopic xenograft model,
metastasis to the liver and lungs could be identified, and a trend of increasing mRNA expression was also observed
in tumors that had metastasized to the liver. This study did not investigate all the mechanisms of the Wnt/β-catenin
signaling pathway in depth; however, it demonstrated that with MNPs, prolonged exposure to an external magnetic
field can cause genetic changes in glioblastoma and changes in tumor growth. This helps understanding of the
correlation between MNPs and an external magnetic field.
Future perspective
This study provides guidance on genetic changes in studies that use MNPs and an external magnetic field. Because
numerous metal-based nanoparticles are used in nanomedicine (e.g., iron, zinc and manganese), it will be important
to extend this type of research to other MNPs and other tumor cells.
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Executive summary
• Magnetic nanoparticles have been studied in many applications that use external magnetic fields, but little is
known about the genetic changes they cause.
• Manganese ferrite magnetic nanoparticles (MFMNPs) are known not only to have high magnetization but also to
obtain ultrasensitive targeted T2 magnetic resonance images in vivo.
• Long-term exposure of glioblastoma cells to MFMNPs and an external magnetic field has shown changes in mRNA
expression.
• There was no significant change in mRNA expression when MFMNPs or an external magnetic field were used
alone.
• When both conditions were satisfied, LRP6 and TCF7 mRNA levels were elevated in U-87MG glioblastoma cells.
• LRP6 and TCF7 are related to the Wnt/β-catenin signaling pathway and promote tumor growth and metastasis.
• MFMNPs and an external magnetic field accelerated tumor growth by about 7 days in a heterotopic xenograft
animal model.
• MFMNPs and an external magnetic field reduced survival rates, with faster tumor growth, in orthotopic
xenograft animal models.
• In a heterotopic xenograft animal model, metastases to the liver and lungs could be confirmed. When affected by
MFMNPs and external magnetic field, TCF7 expression was elevated in metastatic cancer.
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